Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Barette

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Assay and Drug Development Technologies|July 18, 2019
High-Content Screening Identifies New Inhibitors of Connexin 43 Gap JunctionsChristèle Picoli, Emmanuelle Soleilhac, Agnès Journet, et al.
Cell Cycle (Georgetown, Tex.)|February 18, 2009
Benzo[e]pyridoindoles, novel inhibitors of the aurora kinasesThi My-Nhung Hoang, Bertrand Favier, Annie Valette, et al.
Biochimica Et Biophysica Acta|August 5, 2008
Salicylaldehyde derivatives as new protein kinase CK2 inhibitorsRenaud Prudent, Miriam López-Ramos, Virginie Moucadel, et al.
SLAS Discovery : Advancing Life Sciences R & D|September 11, 2020
Quantitative Automated Assays in Living Cells to Screen for Inhibitors of Hemichannel FunctionEmmanuelle Soleilhac, Marjorie Comte, Anaelle da Costa, et al.
Plant Physiology|March 15, 2018
Screening for Biologically Annotated Drugs That Trigger Triacylglycerol Accumulation in the Diatom <i>Phaeodactylum</i>Melissa Conte, Josselin Lupette, Khawla Seddiki, et al.
Metabolites|January 21, 2023
Investigation of Chemical Composition and Biological Activities of <i>Ajuga pyramidalis</i>-Isolation of Iridoids and Phenylethanoid GlycosidesAnthonin Gori, Benjamin Boucherle, Aurélien Rey, et al.
ACS Chemical Biology|March 4, 2020
Förster Resonance Energy Transfer Based Biosensor for Targeting the hNTH1-YB1 Interface as a Potential Anticancer Drug TargetMuge Senarisoy, Caroline Barette, Françoise Lacroix, et al.
Blood Vessels, Thrombosis & Hemostasis|April 9, 2026
Screening chemical libraries for the development of oral treatments for bleeding disordersRenaud Zelli, Landry Seyve, Marie-Claire Dagher, et al.
Frontiers in Pharmacology|May 20, 2020
A New Quantitative Cell-Based Assay Reveals Unexpected Microtubule Stabilizing Activity of Certain Kinase Inhibitors, Clinically Approved or in the Process of ApprovalSacnicte Ramirez-Rios, Sophie Michallet, Leticia Peris, et al.
European Journal of Medicinal Chemistry|June 11, 2021
Synthesis and biological evaluation of chalcone-polyamine conjugates as novel vectorized agents in colorectal and prostate cancer chemotherapyBenjamin Rioux, Aline Pinon, Aurélie Gamond, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Assay and Drug Development Technologies|July 18, 2019
High-Content Screening Identifies New Inhibitors of Connexin 43 Gap JunctionsChristèle Picoli, Emmanuelle Soleilhac, Agnès Journet, et al.
Cell Cycle (Georgetown, Tex.)|February 18, 2009
Benzo[e]pyridoindoles, novel inhibitors of the aurora kinasesThi My-Nhung Hoang, Bertrand Favier, Annie Valette, et al.
Biochimica Et Biophysica Acta|August 5, 2008
Salicylaldehyde derivatives as new protein kinase CK2 inhibitorsRenaud Prudent, Miriam López-Ramos, Virginie Moucadel, et al.
SLAS Discovery : Advancing Life Sciences R & D|September 11, 2020
Quantitative Automated Assays in Living Cells to Screen for Inhibitors of Hemichannel FunctionEmmanuelle Soleilhac, Marjorie Comte, Anaelle da Costa, et al.
Plant Physiology|March 15, 2018
Screening for Biologically Annotated Drugs That Trigger Triacylglycerol Accumulation in the Diatom <i>Phaeodactylum</i>Melissa Conte, Josselin Lupette, Khawla Seddiki, et al.
Metabolites|January 21, 2023
Investigation of Chemical Composition and Biological Activities of <i>Ajuga pyramidalis</i>-Isolation of Iridoids and Phenylethanoid GlycosidesAnthonin Gori, Benjamin Boucherle, Aurélien Rey, et al.
ACS Chemical Biology|March 4, 2020
Förster Resonance Energy Transfer Based Biosensor for Targeting the hNTH1-YB1 Interface as a Potential Anticancer Drug TargetMuge Senarisoy, Caroline Barette, Françoise Lacroix, et al.
Blood Vessels, Thrombosis & Hemostasis|April 9, 2026
Screening chemical libraries for the development of oral treatments for bleeding disordersRenaud Zelli, Landry Seyve, Marie-Claire Dagher, et al.
Frontiers in Pharmacology|May 20, 2020
A New Quantitative Cell-Based Assay Reveals Unexpected Microtubule Stabilizing Activity of Certain Kinase Inhibitors, Clinically Approved or in the Process of ApprovalSacnicte Ramirez-Rios, Sophie Michallet, Leticia Peris, et al.
European Journal of Medicinal Chemistry|June 11, 2021
Synthesis and biological evaluation of chalcone-polyamine conjugates as novel vectorized agents in colorectal and prostate cancer chemotherapyBenjamin Rioux, Aline Pinon, Aurélie Gamond, et al.
Pageof 4